Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Remarks as Prepared for Delivery by Lauren Manning
-
SPEECH EXCERPTS: Select Remarks from Tuesday Night's Program at the Democratic National Convention
-
Rick Miller and Randall Miles Join eXp World Holdings Board of Directors
-
Cantor Fitzgerald Downgrades Relypsa, Inc. (RLYP) to Hold
-
Gladstone Commercial Corporation Reports Results for the Second Quarter Ended June 30, 2016
-
Streetinsider.com's Hot Lunchtime Reads 7/25: (TRP) (WHR) (ALDR) (TBRA)
-
Tobira Therapeutics (TBRA) PT Cut to $19 at Cantor Fitzgerald; Keeps 'Buy'
-
Aurinia Establishes At-The-Market Facility
-
Conyers Park Acquisition Corp. Announces Closing of Initial Public Offering
-
PlacementTracker Announces First Half of 2016 ATM Financing League Tables
-
Conyers Park Acquisition Corp. Announces Pricing of $375 Million Initial Public Offering
-
Spark Therapeutics (ONCE): Reiterated Buy After Gene Therapy Panel - Cantor Fitzgerald
-
Orchid Island Capital Announces July 2016 Monthly Dividend and June 30, 2016 Rmbs Portfolio Characteristics
-
'Leprechaun economics' leaves Irish growth story in limbo
-
RespireRx Pharmaceuticals Inc. to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference on July 13, 2016
-
M III Acquisition Corp. Announces Closing Of Initial Public Offering
-
Great Panther Silver completes previously announced US$29.9 million bought deal offering of units
-
Altimmune to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Jounce Therapeutics to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
MannKind Corporation to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
CORRECTING and REPLACING Cerus to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference on July 13, 2016
-
Progenics Pharmaceuticals to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Auris Medical to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference on Tuesday, July 12
-
InVivo Therapeutics to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Advaxis to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Inotek Pharmaceuticals to Present at Upcoming Investor Conferences
-
Spark Therapeutics Announces Participation in Conferences in July
-
Nicox to present at Cantor Fitzgerald's 2nd Annual Healthcare Conference
-
Nobilis to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference
-
Array BioPharma To Present At The Cantor Fitzgerald 2nd Annual Healthcare Conference
-
OncoMed Management to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference
-
Fibrocell to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Tonix Pharmaceuticals to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Ekso Bionics™ to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Lexicon To Present At The Cantor Fitzgerald Healthcare Conference
-
Ignyta to Present at 2016 Cantor Fitzgerald Healthcare Conference
-
Celldex Therapeutics to Participate in the Cantor Fitzgerald 2nd Annual Healthcare Conference
-
Unusual 11 Mid-Day Movers 7/7: (LEDS) (USEG) (AVG) Higher; (GPL) (SEV) (FLSR) Lower
-
M III Acquisition (MIII) Prices 15M Units IPO for Proceeds of $150M
-
M III Acquisition Corp. Announces Pricing of $150 Million Initial Public Offering
-
CymaBay Announces Participation at Cantor Fitzgerald Healthcare Conference on July 12th in New York
-
Celsion Corporation to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Cantor Fitzgerald Starts Cerus (CERS) at Buy
-
Omeros to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
-
AGTC to Present at the Cantor Fitzgerald Second Annual Healthcare Conference on July 13, 2016
-
Syndax Pharmaceuticals to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
-
NewLink Genetics to Participate in Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Egalet to Present at Cantor Fitzgerald Healthcare Conference
-
Great Panther Silver increases previously announced bought deal financing to US$26 million
